Prot#NU 10H06: Correlative Studies In Conjunction with A Phase 2 Trial of Alemtuzumab-Ofatumumab Combination In Previously Untreated Symptomatic Chronic Lymphocytic Leukemia

Project: Research project

Project Details

StatusActive
Effective start/end date5/20/115/20/21

Funding

  • National Comprehensive Cancer Network (NU 10H06)
  • Novartis Pharmaceuticals Corporation (NU 10H06)